The company need to update16 Feb 2019 11:20
I dont believe this buying for time malarkey...what is wrong with them just stating they need more time because of the shutdown...but they would rather decimate investors money and the future of the said business...i dont believe it!
The truth is that if mtfb have nothing to hide they should be in a room now with the best industry specialist going through the crl, matching it to thier submission, compairing it against vany etc and matching it to other drugs that have been approved or rejected for liver toxicity.
Then...they should be updating the market on good or bad news.
If not, they are hiding....if iclaprim works equally as well as vany with no more adverse side effects on toxacity and costs a lot less then they should be taking the lead on this.
I just cannot see what another trial would prove that would make the fda change their minds...1300 patients, its already mega!
Either the fds dont want to disturb the vany monopoly or they know something about iclaprim that our bod are not telling us...either way, its a scandal.